Roche Provides Info About Ongoing HD Program & Announces Two Upcoming Trials; HDSA to Host Webinar
Posted on September 20, 2018
This past Sunday at the plenary meeting of the European Huntington’s Disease Network (EHDN), Roche Pharmaceuticals announced some details about…
Read MoreRegister for the Upcoming HDSA Webinar with Roche/Genentech on Wed. September 26th
Posted on September 13, 2018
This week, members of the HDSA team are attending the 2018 plenary meeting of the European Huntington’s Disease Network (EHDN)…
Read MoreInterview with 2018 Berman-Topper Fellow – Dr. Rachel Harding
Posted on September 6, 2018
This week, meet Dr. Rachel Harding from the University of Toronto, the recipient of this year’s Berman-Topper Family HD Career…
Read MoreHD Featured in Science Magazine
Posted on August 30, 2018
The prestigious Science magazine published an article on Huntington’s disease this week, describing the huntingtin-lowering ASO drug developed by Ionis,…
Read MoreProposal to Streamline Gene Therapy Evaluation by the FDA
Posted on August 23, 2018
This week, the FDA released a proposal to streamline the way they oversee the evaluation of protocols related to gene…
Read More